Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
CD44 — a sticky target for asthma
Marc E. Rothenberg
Marc E. Rothenberg
Published May 15, 2003
Citation Information: J Clin Invest. 2003;111(10):1460-1462. https://doi.org/10.1172/JCI18392.
View: Text | PDF
Commentary

CD44 — a sticky target for asthma

  • Text
  • PDF
Abstract

Authors

Marc E. Rothenberg

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
Overview of immunological mechanisms in the development of allergic eosi...
Overview of immunological mechanisms in the development of allergic eosinophilic airway inflammation involving CD44. There are multiple mechanisms by which CD44 may effect the propagation and resolution of allergic airway inflammation. Engagement of CD44 by a variety of ligands (typically extracellular matrix components such as HA) on CD4+ T cells and eosinophils promotes cellular chemotaxis, activation, and survival. Th2 cell-derived IL-4 and IL-13 potently induce critical chemokines (including TARC and the eotaxins) by several resident cells in the lung (e.g., respiratory epithelium), and induce direct asthma responses (including mucus production and airway hyperreactivity). Eosinophils further exacerbate allergic inflammation by production of potent smooth muscle constrictors (e.g., LTs) and by the cytotoxic effects of their granule proteins on lung cells. CD44 may also have an important role in resolution of allergic airway inflammation by promoting the removal of apoptotic airway cells by macrophage-mediated CD44-dependent phagocytosis and clearance.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts